Chronic inducible urticaria: confirmation through challenge tests and response to treatment

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorPEREIRA, Amanda Rocha Firmino
dc.contributor.authorMOTTA, Antonio Abilio
dc.contributor.authorKALIL, Jorge
dc.contributor.authorAGONDI, Rosana Camara
dc.date.accessioned2020-10-15T14:30:52Z
dc.date.available2020-10-15T14:30:52Z
dc.date.issued2020
dc.description.abstractObjective: To evaluate the positivity of challenge tests of patients suspected of chronic inducible urticaria and the response to treatment. Methods: A retrospective study of electronic medical records of patients suspected of chronic inducible urticaria. All patients were submitted to challenge tests with triggering stimuli, according to the clinical history and, subsequently, the response to drug treatment was evaluated. Results: A total of 191 patients with suspected chronic inducible urticaria were included. It was confirmed in 118 patients and 122 positive tests (4 patients with 2 different positive tests). Most had dermographic urticaria (70.3%), followed by cholinergic urticaria (17.8%). Regarding treatment, 28% responded to antihistamine in licensed doses, 34.7% with increased doses, 9.3% responded to the addition of another medication. The concomitance of chronic inducible urticaria and chronic spontaneous urticaria was found in 35.3% of patients, being more frequent in females, with longer time to control symptoms and higher frequency of cholinergic urticaria. Conclusion: The confirmation of chronic inducible urticaria in patients with this suspicion, after challenge tests, was high. There was a good response to antihistamine. In the concomitance of chronic spontaneous urticaria, longer time to control symptoms and higher frequency of cholinergic urticaria were observed.eng
dc.description.indexMEDLINEeng
dc.identifier.citationEINSTEIN-SAO PAULO, v.18, article ID eAO5175, 8p, 2020
dc.identifier.doi10.31744/einstein_journal/2020AO5175
dc.identifier.eissn2317-6385
dc.identifier.issn1679-4508
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/37671
dc.language.isoeng
dc.publisherINST ISRAELITA ENSINO & PESQUISA ALBERT EINSTEINeng
dc.relation.ispartofEinstein-Sao Paulo
dc.rightsopenAccesseng
dc.rights.holderCopyright INST ISRAELITA ENSINO & PESQUISA ALBERT EINSTEINeng
dc.subjectUrticariaeng
dc.subjectAngioedemaeng
dc.subjectDiagnosiseng
dc.subjectDrug therapyeng
dc.subjectDose-response relationshipeng
dc.subjectdrugeng
dc.subject.otherphysical urticariaseng
dc.subject.othercold urticariaeng
dc.subject.otherimpacteng
dc.subject.otherclassificationeng
dc.subject.otherprevalenceeng
dc.subject.otherguidelineseng
dc.subject.othermanagementeng
dc.subject.othertoleranceeng
dc.subject.wosMedicine, General & Internaleng
dc.titleChronic inducible urticaria: confirmation through challenge tests and response to treatmenteng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus7
hcfmusp.contributor.author-fmusphcAMANDA ROCHA FIRMINO PEREIRA
hcfmusp.contributor.author-fmusphcANTONIO ABILIO MOTTA
hcfmusp.contributor.author-fmusphcJORGE ELIAS KALIL FILHO
hcfmusp.contributor.author-fmusphcROSANA CAMARA AGONDI
hcfmusp.description.articlenumbereAO5175
hcfmusp.description.volume18
hcfmusp.origemWOS
hcfmusp.origem.pubmed32667419
hcfmusp.origem.scieloSCIELO:S1679-45082020000100257
hcfmusp.origem.scopus2-s2.0-85088249336
hcfmusp.origem.wosWOS:000557372400001
hcfmusp.publisher.citySAO PAULO SPeng
hcfmusp.publisher.countryBRAZILeng
hcfmusp.relation.referenceAbajian M, 2014, IMMUNOL ALLERGY CLIN, V34, P73, DOI 10.1016/j.iac.2013.09.010eng
hcfmusp.relation.referenceBalp MM, 2017, DERMATOLOGY THER, V7, P547, DOI 10.1007/s13555-017-0200-7eng
hcfmusp.relation.referenceBLACK AK, 1979, LANCET, V2, P964eng
hcfmusp.relation.referenceBlack AK, 1996, CLIN EXP DERMATOL, V21, P424, DOI 10.1111/j.1365-2230.1996.tb00146.xeng
hcfmusp.relation.referenceDias GAC, 2016, AN BRAS DERMATOL, V91, P754, DOI 10.1590/abd1806-4841.20165071eng
hcfmusp.relation.referenceCurto-Barredo L, 2018, ACTA DERM-VENEREOL, V98, P641, DOI 10.2340/00015555-2941eng
hcfmusp.relation.referenceDressler C, 2018, J ALLERGY CLIN IMMUN, V141, P1726, DOI 10.1016/j.jaci.2018.01.031eng
hcfmusp.relation.referenceDuarte RA, 2018, ARQ ASMA ALERG IMUNO, V2, P434eng
hcfmusp.relation.referenceGeller M, 2007, EINSTEIN-SAO PAULO, V5, P273eng
hcfmusp.relation.referenceGrob JJ, 2005, BRIT J DERMATOL, V152, P289, DOI 10.1111/j.1365-2133.2005.06385.xeng
hcfmusp.relation.referenceGuillen-Aguinaga S, 2016, BRIT J DERMATOL, V175, P1153, DOI 10.1111/bjd.14768eng
hcfmusp.relation.referenceKocaturk E, 2017, J DERMATOL SCI, V87, P60, DOI 10.1016/j.jdermsci.2017.02.283eng
hcfmusp.relation.referenceKontouFili K, 1997, ALLERGY, V52, P504, DOI 10.1111/j.1398-9995.1997.tb02593.xeng
hcfmusp.relation.referenceLEIGH IM, 1974, T ST JOHNS HOSP DERM, V60, P40eng
hcfmusp.relation.referenceLEIGH IM, 1975, BRIT J DERMATOL, V92, P191, DOI 10.1111/j.1365-2133.1975.tb03057.xeng
hcfmusp.relation.referenceLima SO, 2008, REV BRAS ALERG IMUNO, V31, P220eng
hcfmusp.relation.referenceMagerl M, 2016, ALLERGY, V71, P780, DOI 10.1111/all.12884eng
hcfmusp.relation.referenceMaurer M, 2018, J ALLER CL IMM-PRACT, V6, P1119, DOI 10.1016/j.jaip.2018.03.007eng
hcfmusp.relation.referenceMaurer M, 2018, J ALLERGY CLIN IMMUN, V141, P638, DOI 10.1016/j.jaci.2017.06.032eng
hcfmusp.relation.referenceMetz M, 2011, INT ARCH ALLERGY IMM, V154, P177, DOI 10.1159/000320233eng
hcfmusp.relation.referenceODonnell BF, 1997, BRIT J DERMATOL, V136, P197eng
hcfmusp.relation.referenceRAMSAY CA, 1977, ARCH DERMATOL, V113, P1222, DOI 10.1001/archderm.113.9.1222eng
hcfmusp.relation.referenceSanchez J, 2017, J ALLER CL IMM-PRACT, V5, P464, DOI 10.1016/j.jaip.2016.09.029eng
hcfmusp.relation.referenceSchoepke N, 2015, J EUR ACAD DERMATOL, V29, P708, DOI 10.1111/jdv.12661eng
hcfmusp.relation.referenceSilpa-archa N, 2011, J EUR ACAD DERMATOL, V25, P1194, DOI 10.1111/j.1468-3083.2010.03951.xeng
hcfmusp.relation.referenceTrevisonno J, 2015, POSTGRAD MED, V127, P565, DOI 10.1080/00325481.2015.1045817eng
hcfmusp.relation.referenceWARIN RP, 1987, BRIT J DERMATOL, V116, P742, DOI 10.1111/j.1365-2133.1987.tb05913.xeng
hcfmusp.relation.referenceZuberbier H C Torsten, 2014, IMMUNOL ALLERGY CLIN, V34, pxixeng
hcfmusp.relation.referenceZuberbier T, 2018, ALLERGY, V73, P1393, DOI 10.1111/all.13397eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication7e27eb21-3423-4e6a-bcf3-d17d43dc303c
relation.isAuthorOfPublication39bb0832-f3af-40e0-943c-80f1ef4b573c
relation.isAuthorOfPublication039713b4-cdee-430a-b5dd-77d7d751b09b
relation.isAuthorOfPublication083fc8b3-3197-4e38-9361-3c204ac1771e
relation.isAuthorOfPublication.latestForDiscovery7e27eb21-3423-4e6a-bcf3-d17d43dc303c
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_PEREIRA_Chronic_inducible_urticaria_confirmation_through_challenge_tests_and_2020.PDF.pdf
Tamanho:
530.29 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/19
Artigos e Materiais de Revistas Científicas - LIM/60